Emily J Anstadt

2PUBLICATIONS
2CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Oct 12, 2023
SMAD4 loss predicts worse overall and distant metastasis-free survival in patients with resected pancreatic adenocarcinoma.

Emily J Anstadt, Ruben Carmona, Eva Berlin

|Jun 06, 2022
Moderate Colitis Not Requiring Intravenous Steroids Is Associated with Improved Survival in Stage IV Melanoma after Anti-CTLA4 Monotherapy, But Not Combination Therapy.

Emily J Anstadt, Brian Chu, Nikhil Yegya-Raman

Pageof 1

Frequent Collaborators

1 joint publications

Brian Chu

1 joint publications

Andrea Facciabene